Narasimha Reddy Molugu

Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152

R. Ravikrishnan, A. Awasthi, K. Ella, 2020 .

Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152

R. Ravikrishnan, A. Awasthi, K. Ella, 2020, bioRxiv.

Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation

R. Ravikrishnan, A. Awasthi, K. Ella, 2021, iScience.